eleva Alternatives & Competitors
12 companies similar to eleva — Next level medicine with ease. Powered by moss.
Companies similar to eleva
Allena Pharmaceuticals, Inc.
Developing Therapeutics for Patients with Rare and Severe Metabolic and Kidney Disorders
Newton, United States
Dianthus Therapeutics, Inc.
Building a leading biotech company focused in severe autoimmune diseases.
United States
KAMADA
Specialty Plasma-Derived Therapeutics
Rehovot, Israel
Visterra Inc.
We bring better biologics to life. Biospace Best Place to Work 2024!
Waltham, United States
Track all eleva competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Angitia Biopharmaceuticals
Developing innovative medicines to address serious musculoskeletal diseases
Westlake Village, United...
Ansun Biopharma, Inc.
Discovering solutions for the world
San Diego, United States
Montis Biosciences
Pioneering next-gen therapeutics to harness C1q's central role in neuroinflammatory diseas...
Belgium
Pathalys Pharma
Our mission is to improve the lives of patients through enhanced therapeutics to advance t...
Raleigh, United States
CryptoMedix
Pioneering therapeutic advancements in cancer and inflammatory diseases by targeting uniqu...
OncXerna Therapeutics
Advancing a new paradigm of precision oncology with a RNA-based approach to match patients...
Waltham, United States
AusperBio
Transforming Patient Lives For a Better Tomorrow
San Mateo, United States
Attovia Therapeutics
Creating medicines for immune-mediated disease using ATTOBODY®, a proprietary biologics pl...
San Carlos, United States
About eleva
Eleva, a pioneering biopharmaceutical firm headquartered in Germany, is committed to transforming the landscape of medicine through its innovative, moss-based technology. Founded in 1999, Eleva is on the cutting edge of biotechnology, focusing on the discovery and development of previously inaccessible biological thera...
Development of biologics, Clinical trials for new therapies, Biotechnology platform development
Patients with complement disorders, Healthcare providers, Pharmaceutical partnerships, Research institutions
Biopharmaceuticals, Clinical-stage Therapeutics, Precision Complement Modulation, Kidney Disorders, Dry AMD, Complement-driven Diseases, Moss-based Technology, Biologics Production, Antibodies, Replacement Enzymes, Fusion Toxins, Rare Diseases Treatment, Renal Diseases, Clinical Development
B2B, Platform
Product Sales, Licensing, Value Based Pricing
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches eleva and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at eleva on 14 May 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
